PATENT CLAIM ANALYSIS

Application Number: 15509466
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "049000"]

Abstract:
The present invention relates to cysteamine, cystamine, or derivatives thereof, for use in the treatment and/or prevention of infection caused by the bacterium,  Mycobacterium  spp., in particular  Mycobacterium abscessus , or a disease or condition associated therewith.

Claim (Index 10):
A method of treating an infection caused by the bacterium,  Mycobacterium  spp., or disease or condition therewith associated in a patient comprising administering an effective amount of an amino thiol compound, or pharmaceutically acceptable salt thereof, to the patient.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 90.0
- Lexical Diversity: 1.30303
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14460953', '15669289', '14675218', '13945257', '13349789']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7059292308433797
- 35 USC 102 Novelty (BERT): 0.4819004499419829
- Combined Prediction Score: 0.68352635275324
- Mean Citation Score: 192.27938
- Max Citation Score: 197.42651
- Similarity Product: 146.29715012143018

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test